Boston Scientific Corp (NYSE:BSX)
| 44.08 Delayed Data As of Dec 06 |  +0.82 / +1.90%Today’s Change | 31.56 Today|||52-Week Range 44.22 | +24.73% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Mahoney Michael F Chairman, President & Chief Executive Officer |  Sale | 2/20/2019 | 103,012 | $40.11 | $4.1M | +9.90% |
Brennan Daniel J /boston/ Chief Financial Officer & Executive Vice President | Sale | 3/04/2019 | 64,223 | $40.84 | $2.6M | +9.38% |
Mackey Edward EVP-Operations | Sale | 5/01/2019 | 55,320 | $36.83 | $2.0M | +21.17% |
Mahoney Michael F Chairman, President & Chief Executive Officer | Sale | 1/01/2019 | 54,758 | $35.34 | $1.9M | +27.92% |
Brennan Daniel J /boston/ Chief Financial Officer & Executive Vice President | Sale | 3/14/2019 | 46,360 | $40.02 | $1.9M | +10.06% |
Fitzgerald Joseph M | Sale | 2/12/2019 | 44,236 | $40.00 | $1.8M | +10.09% |
Nanavaty Maulik K SVP & President-Neuromodulation | Sale | 8/29/2019 | 34,035 | $42.64 | $1.5M | +2.89% |
Mackey Edward EVP-Operations | Sale | 3/11/2019 | 35,906 | $39.72 | $1.4M | +10.48% |
Carruthers Wendy Senior Vice President-Human Resources | Sale | 3/11/2019 | 29,412 | $39.63 | $1.2M | +10.48% |
Brennan Daniel J /boston/ Chief Financial Officer & Executive Vice President | Sale | 2/20/2019 | 25,753 | $40.11 | $1.0M | +9.90% |
Page of 25